News|Articles|August 1, 2023
Application of MicroCoat TM technology to mask bitter taste of Amodiaquine and Artesunate in a combination antimalarial formulation for oral paediatric administration
Author(s)Mikart
Formulating a Fixed Dose Combination (FDC) of Artesunate (AS) and Amodiaquine (AQ) as taste masked micropellets for oral administration to children under 5 years.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
2
Mirum Acquires Bluejay, Adding Brelovitug Treatment for HDV
3
GSK’s RSV Vaccine Approved in Europe
4
How Digitalization Is Transforming Pharmaceutical Manufacturing Processes
5